Advancing the standard of care in incision management with 3M™ Prevena™ Therapy.
Higher standards in healthcare call for a higher standard of therapy. Now you can take post-operative care to new levels and provide your patients with protection from post-surgical complications with closed incision negative pressure therapy (ciNPT).
Learn more about Prevena Therapy
The costly reality of at-risk incisions
In an increasingly complex healthcare environment, surgeons are faced with unique challenges that can negatively affect outcomes. Effectively managing the risk of postoperative complication is a priority.
- Surgical site infections (SSIs) account for 22%-36% of all healthcare-associated infections (HAIs).1,2
- Patients with an SSI are 6X more likely to have a 30-day readmission.3
- The average added cost from SSIs is $38,656.4
- A patient who develops an SSI has on average a 9.58 day longer hospital stay.4
- A patient who develops an SSI has on average a 2.2X longer ICU stay.3
Help improve patient outcomes
In a newly published 2023 Multi-Specialty Meta-Analysis, Prevena Therapy has demonstrated significant improvement in key patient outcomes across multiple specialties.5
-
46% Reduction in SSCs -
48% Reduction in SSIs -
36% Reduction in return to OR -
23% Reduction in readmission
Proactive Risk Management (PRM) with Prevena Therapy provides healthcare professionals with an evidence-based, standardized approach that helps to advance the standard of care for ciNPT. This intuitive, actionable model is grounded in level 1, 2 and 3 clinical evidence to help support you through procedural and patient risk stratification.
Learn about Proactive Risk Management (PRM) with Prevena Therapy.
-
Seeing is believing. Experience Prevena Therapy though a virtual or in-person interactive product demonstration.
- Feel how our advanced incision dressing design allows for movement, enhancing the post-operative rehabilitation process.
- Walk through the dressing components and the application process.
- Dialogue with knowledgeable team members throughout the demonstration, gaining insights along the way that are relevant to your specific needs.
- Choose from 3M™ Prevena™ Dressings or 3M™ Prevena Restor™ Dressings.
- Request a demonstration
-
-
This helpful website explains what to expect while a patient is using Prevena Therapy. Patients can find instructions, information on caring for the system, and frequently asked questions.
Talk to a representative or request a product demonstration
Our apologies...
An error has occurred while submitting. Please try again later...
Thank you!
Your form was submitted successfully
The brands listed above are trademarks of 3M.
NOTE: Specific indications, limitations, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. Rx only.
3M™ Prevena™ 125 and 3M™ Prevena™ Plus 125 Therapy Units manage the environment of closed surgical incisions and remove fluid away from the surgical incision via the application of -125mmHg continuous negative pressure. When used with legally marketed compatible dressings, Prevena 125 and Prevena Plus 125 Therapy Units are intended to aid in reducing the incidence of seroma and, in patients at risk for post-operative infections, aid in reducing the incidence of superficial surgical site infection in Class I and II wounds.
The effectiveness of Prevena Therapy in reducing the incidence of SSIs and seroma in all surgical procedures and populations has not been demonstrated. See full indications for use and limitations at hcbgregulatory.3m.com/
References:
1. Zimlichman E, Henderson D, Tamir, et al. Health care-associated Infections a meta-analysis of costs and financial impact on the U.S. health care system. JAMA Interned.2013;173(22):20-46.
2. Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care-associated Infections. N Engl JMed: 2014;370:1198-208.
3. Shepard J, Ward W, Milstone A, et al. Financial impact of surgical site infections on hospitals. The hospital management perspective. JAMA Surg. 2013;148(10):907-914.doi:10.1001/jamasurg.2013.2246 Published online August 21, 2013.
4. Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA. 2003;290(14):1868-1874.
5. Cooper HJ, Singh DP, Gabriel A, Mantyh C, Silverman R, Griffin L. Closed Incision Negative Pressure Therapy Versus Standard of Care Over Closed Surgical Incisions in the Reduction of Surgical Site Complications: A Systematic Review and Meta-Analysis of Comparative Studies. Plastic and Reconstructive Surgery – Global Open. 2023 Mar 16;11(3):e4722.
